25 Jan 2022 , 05:19 PM
Net profit of Astec Lifesciences rose 250.57% to Rs 24.75 crore in the quarter ended December 2021 as against Rs 7.06 crore during the previous quarter ended December 2020. Sales rose 49.43% to Rs 173.35 crore in the quarter ended December 2021 as against Rs 116.01 crore during the previous quarter ended December 2020.
| Particulars | Quarter Ended | ||
| ? | Dec. 2021 | Dec. 2020 | % Var. |
| Sales | 173.35 | 116.01 | 49 |
| OPM % | 24.72 | 13.43 | – |
| PBDT | 42.26 | 17.80 | 137 |
| PBT | 33.21 | 11.28 | 194 |
| NP | 24.75 | 7.06 | 251 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
